We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
(+27%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$57.7M |
| 2 |
Broadcom
AVGO
|
+$13.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.3M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$9.41M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$1.27M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$1.24M |
| 3 |
AstraZeneca
AZN
|
+$1.1M |
| 4 |
GREK
Global X MSCI Greece ETF
GREK
|
+$1.07M |
| 5 |
HIMU
iShares High Yield Muni Active ETF
HIMU
|
+$779K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Financials | 6.8% |
| 3 | Industrials | 6.1% |
| 4 | Consumer Discretionary | 4.96% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
2351
Trueblue
TBI
$311M
| $5.53K | ﹤0.01% |
1,414
-3,982
| -74% | -$17.7K |
|
2352
LSB Industries
LXU
$693M
| $5.51K | ﹤0.01% |
370
| – | – |
|
2353
Caesars Entertainment
CZR
$6.14B
| $5.47K | ﹤0.01% |
207
+173
| +509% | +$4.12K |
|
2354
Arrowhead Research
ARWR
$12.4B
| $5.46K | ﹤0.01% |
87
| – | – |
|
|
INGM
2355
Ingram Micro Holding
INGM
$6.55B
| $5.46K | ﹤0.01% |
234
+56
| +31% | +$1.22K |
|
|
CPRX
2356
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.4K | ﹤0.01% |
218
+205
| +1,577% | +$4.88K |
|
2357
Redwire
RDW
$3.25B
| $5.39K | ﹤0.01% |
634
+7
| +1% | +$69 |
|
2358
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $5.38K | ﹤0.01% |
42
| – | – |
|
2359
Americold
COLD
$4.27B
| $5.38K | ﹤0.01% |
469
+58
| +14% | +$727 |
|
2360
Mirum Pharmaceuticals
MIRM
$6.14B
| $5.36K | ﹤0.01% |
58
| – | – |
|
2361
Hertz
HTZ
$809M
| $5.35K | ﹤0.01% |
1,161
| – | – |
|
|
NXDT
2362
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $5.3K | ﹤0.01% |
+1,134
| New | +$5.08K |
|
2363
Under Armour Class C
UA
$2.53B
| $5.28K | ﹤0.01% |
+912
| New | +$5.75K |
|
2364
AtriCure
ATRC
$2.11B
| $5.28K | ﹤0.01% |
185
+139
| +302% | +$4.74K |
|
2365
Campbell Soup
CPB
$6.87B
| $5.26K | ﹤0.01% |
236
-306
| -56% | -$7.86K |
|
2366
Empire State Realty Trust
ESRT
$836M
| $5.25K | ﹤0.01% |
1,009
+960
| +1,959% | +$5.76K |
|
2367
HBT Financial
HBT
$1.32B
| $5.21K | ﹤0.01% |
195
+35
| +22% | +$953 |
|
2368
Bentley Systems
BSY
$10.6B
| $5.2K | ﹤0.01% |
148
+120
| +429% | +$4.41K |
|
2369
Woori Financial
WF
$17.6B
| $5.2K | ﹤0.01% |
+78
| New | +$5.25K |
|
2370
Tootsie Roll Industries
TR
$2.98B
| $5.17K | ﹤0.01% |
121
+53
| +78% | +$2.08K |
|
2371
Omega Flex
OFLX
$312M
| $5.12K | ﹤0.01% |
165
+119
| +259% | +$3.91K |
|
2372
Expro Ltd
XPRO
$1.91B
| $5.12K | ﹤0.01% |
294
| – | – |
|
|
AD
2373
Array Digital Infrastructure
AD
$3.05B
| $5.08K | ﹤0.01% |
110
| – | – |
|
2374
Scilex Holding
SCLX
$48.9M
| $5.07K | ﹤0.01% |
761
| – | – |
|
2375
RH
RH
$3.71B
| $5.03K | ﹤0.01% |
36
+5
| +16% | +$911 |
|
Similar funds
FLAM
AIM
MTCM
CNC
RIM
C
HH
EIA
Versant Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.
- Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
- Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
- Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
- Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
- Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
- Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
- Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.